BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 2879448)

  • 1. Characterization of the in vivo and in vitro inhibition of gastrin secretion from gastrinoma by a somatostatin analogue (SMS 201-995).
    Ellison EC; Gower WR; Elkhammas E; Woltering EA; Sparks J; O'Dorisio TM; Fabri PJ
    Am J Med; 1986 Dec; 81(6B):56-64. PubMed ID: 2879448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Observations on the effect of a somatostatin analog in the Zollinger-Ellison syndrome: implications for the treatment of apudomas.
    Ellison EC; O'Dorisio TM; Sparks J; Mekhjian HS; Fromkes JJ; Woltering EA; Carey LC
    Surgery; 1986 Aug; 100(2):437-44. PubMed ID: 2426819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism for increase of gastrin release by secretin in Zollinger-Ellison syndrome.
    Chiba T; Yamatani T; Yamaguchi A; Morishita T; Nakamura A; Kadowaki S; Fujita T
    Gastroenterology; 1989 Jun; 96(6):1439-44. PubMed ID: 2565843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Failure of secretin to stimulate gastrin release and adenylate cyclase activity in gastrinoma in vitro.
    Ellison EC; O'Dorisio MS; O'Dorisio T; Sparks J; Vasallo L; Woltering EA
    Surgery; 1984 Dec; 96(6):1019-26. PubMed ID: 6095476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastrin secretion by gastrinoma cells in long-term culture.
    Elouaer-Blanc L; Sobhani I; Ruszniewski P; Duet M; Lehy T; Mignon M; Bonfils S; Lewin MJ
    Am J Physiol; 1988 Nov; 255(5 Pt 1):G596-602. PubMed ID: 2847543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Somatostatin analogue (SMS 201-995) in patients with gastrinomas.
    Vinik AI; Tsai S; Moattari AR; Cheung P
    Surgery; 1988 Nov; 104(5):834-42. PubMed ID: 2903562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Somatostatin-like peptides alter calcium but not secretin sensitivity of gastrinoma cells.
    Woltering EA; Ellison EC; O'Dorisio TM; Sparks J; Howe B; Dyben T
    J Surg Res; 1986 Jun; 40(6):605-10. PubMed ID: 2875213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of somatostatin analogue (SMS 201-995) on molecular species of gastrin in gastrinoma.
    Campagnolo D; Gower WR; Fabri PJ; Sparks J; Mekhjian HS; O'Dorisio TM; Ellison EC
    Surgery; 1987 Dec; 102(6):982-7. PubMed ID: 2891204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of somatostatin analog on peptide release and tumor growth in the Zollinger-Ellison syndrome.
    Mozell E; Woltering EA; O'Dorisio TM; Fletcher WS; Sinclair AJ; Hill D
    Surg Gynecol Obstet; 1990 Jun; 170(6):476-84. PubMed ID: 2188384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishment of a human gastrinoma in nude mice.
    Upp JR; Trudel JL; Townsend CM; Alexander RW; Rajaraman S; Nealon WH; Greeley GH; Thompson JC
    Surgery; 1988 Dec; 104(6):1037-45. PubMed ID: 3194831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastrin release from gastrinoma cells stimulated with secretin.
    Imamura M; Adachi H; Takahashi K; Noguchi M; Mizutani N; Nakagawa M; Tobe T
    Dig Dis Sci; 1982 Dec; 27(12):1130-6. PubMed ID: 7172964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postreceptor inhibition of antral gastrin release by somatostatin.
    Harty RF; Maico DG; McGuigan JE
    Gastroenterology; 1985 Mar; 88(3):675-80. PubMed ID: 2857145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of secretin on gastrin release from gastrinoma cells in vitro.
    Elkhammas EA; Gower WR; Woltering EA; O'Dorisio TM; Sparks J; Fabri PJ; Ellison EC
    Surgery; 1986 Dec; 100(6):948-53. PubMed ID: 3787478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-acting somatostatin analog controls acid and gastrin secretion in benign, not in malignant, Zollinger-Ellison syndrome.
    Bauer FE; Hummel M; Merki HS; Schulz E; Oeder R; Marbach P
    J Clin Gastroenterol; 1989 Jun; 11(3):282-6. PubMed ID: 2754214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the effect of somatostatin and an analogue, SMS 201-995, on gastrin and insulin secretion from isolated perfused rat stomach and pancreas.
    Takemura J; Kwok YN; Brown JC
    Am J Med; 1986 Dec; 81(6B):65-73. PubMed ID: 2879449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Control of gastrin release in cultured gastrinoma-derived G cells.
    Gower WR; Buzogany JA; Ellison EC; Knierim TH; Fabri PJ
    Surgery; 1988 Aug; 104(2):424-30. PubMed ID: 2899916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of gastrin release by secretin is mediated by somatostatin in cultured rat antral mucosa.
    Wolfe MM; Reel GM; McGuigan JE
    J Clin Invest; 1983 Nov; 72(5):1586-93. PubMed ID: 6138366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-acting somatostatin (SMS 201-995) in the management of Zollinger-Ellison syndrome: evidence for sustained efficacy.
    Ruszniewski P; Laucournet H; Elouaer-Blanc L; Mignon M; Bonfils S
    Pancreas; 1988; 3(2):145-52. PubMed ID: 2897687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of somatostatin analog in gastroenteropancreatic tumors other than carcinoid.
    Vinik AI; Lloyd R; Cho K
    Metabolism; 1990 Sep; 39(9 Suppl 2):156-62. PubMed ID: 2402220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rebound hypergastrinemia after cessation of a somatostatin analogue (SMS 201-995) in malignant gastrinoma.
    Buck M; Kvols LK; O'Dorisio TM
    Am J Med; 1987 May; 82(5B):92-5. PubMed ID: 2884883
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.